Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Avecure Flexible Microwave Ablation Probe For Lung Nodules

NCT: NCT05281237 · RECRUITING

NCT IDNCT05281237
StatusRECRUITING
Start Date2022-06-01
Completion2027-06-30

Brief Summary

This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)

Frequently Asked Questions

What is Avecure Flexible Microwave Ablation Probe For Lung Nodules?

Avecure Flexible Microwave Ablation Probe For Lung Nodules is a clinical trial registered under NCT05281237. Current status: RECRUITING.

What is the status of NCT05281237?

The current status of NCT05281237 (Avecure Flexible Microwave Ablation Probe For Lung Nodules) is: RECRUITING.

When did Avecure Flexible Microwave Ablation Probe For Lung Nodules start?

Avecure Flexible Microwave Ablation Probe For Lung Nodules started on 2022-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑